Published in
Baishideng Publishing Group, World Journal of Hepatology, 10(6), p. 759, 2014
Links
- Baishideng Publishing Group
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [arxiv.org] | PDF
- [goedoc.uni-goettingen.de] | PDF
- [www.researchgate.net]
- [europepmc.org] | PDF
- [arxiv.org] | PDF
Tools
Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis
Journal article published in 2014 by
Christian Röver 
,
Silke Cameron,
Nicolae-Catalin Mechie,
Ahmad Amanzada
,
Silke Cameron,
Nicolae-Catalin Mechie,
Ahmad Amanzada
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
AIM: To investigate the predictability of interleukin-28B single nucleotide polymorphism rs12979860 with respect to sustained virological response (SVR) in chronically hepatitis C virus (HCV) genotype-1 patients treated with a protease-inhibitor and pegylated interferon-α (Peg-INF-α) based triple-therapy.